Ascentage Pharma Group International
AAPG- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002023311
No open-market purchases or sales by Ascentage Pharma Group International insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $263.5K in total; no superinvestor holds it.
Holders of 5% or more of AAPG
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Ascentage Pharma Group International, largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Ascentage Pharma Group International on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on Ascentage Pharma Group International, newest first.
No Schedule 13D or 13G filings on Ascentage Pharma Group International are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Ascentage Pharma Group International shares.
No Form 144 notices for Ascentage Pharma Group International are on file.